IMPRINT Trademark

Trademark Overview


On Thursday, April 4, 2024, a trademark application was filed for IMPRINT with the United States Patent and Trademark Office. The USPTO has given the IMPRINT trademark a serial number of 98485146. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, January 12, 2026. This trademark is owned by Imprint Labs, LLC. The IMPRINT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Creating, designing and improving of datasets, namely, computational computer modeling using and analyzing immunology data for training artificial intelligence (AI) models and large language models (LLM) to learn patterns and make predictions and visualize data models and training data for identifying druggable targets, antibody sequences and cell therapies in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease for drug, biologics, and vaccine design purposes in the field of medical science and medical consultancy; Providing temporary use of online non-downloadable software for searching, reviewing, analyzing, testing, predicting, inferring, reconstructing, organizing, screening and sharing data, methodologies, and protocols in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease; Providing information about computer computational modeling of methods regarding machine learnin...
imprint

General Information


Serial Number98485146
Word MarkIMPRINT
Filing DateThursday, April 4, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, January 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCreating, designing and improving of datasets, namely, computational computer modeling using and analyzing immunology data for training artificial intelligence (AI) models and large language models (LLM) to learn patterns and make predictions and visualize data models and training data for identifying druggable targets, antibody sequences and cell therapies in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease for drug, biologics, and vaccine design purposes in the field of medical science and medical consultancy; Providing temporary use of online non-downloadable software for searching, reviewing, analyzing, testing, predicting, inferring, reconstructing, organizing, screening and sharing data, methodologies, and protocols in the fields of immunology, immunomics, immunotherapy, psychiatry, neurology, allergy, and infectious disease; Providing information about computer computational modeling of methods regarding machine learning, artificial intelligence (AI) training data, large language models (LLM) to learn patterns and make predictions for identifying etiology, treatment, and prophylaxis of chronic diseases, autoimmunity, psychiatric, neurological disorders, allergy, and infectious disease

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 4, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImprint Labs, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10014

Trademark Events


Event DateEvent Description
Thursday, April 4, 2024NEW APPLICATION ENTERED
Thursday, April 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 18, 2024ASSIGNED TO EXAMINER
Wednesday, October 30, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024NON-FINAL ACTION E-MAILED
Wednesday, October 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, January 29, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, April 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 14, 2025FINAL REFUSAL WRITTEN
Monday, July 14, 2025FINAL REFUSAL E-MAILED
Monday, July 14, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 3, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 3, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 9, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 9, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Saturday, January 10, 2026EXAMINERS AMENDMENT -WRITTEN
Saturday, January 10, 2026EXAMINERS AMENDMENT E-MAILED
Saturday, January 10, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, January 10, 2026EXAMINER'S AMENDMENT ENTERED
Monday, January 12, 2026APPROVED FOR PUB - PRINCIPAL REGISTER